Enabled by our proprietary technology platforms, Empirico is discovering and developing novel siRNA medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease.

Exceptional internal capabilities in human genetics and siRNA chemistry, augmented by those of our partners, drive Empirico’s ever-growing pipeline of differentiated clinical and preclinical programs for common diseases with unmet need.

Our dedicated team of physicians, biologists, chemists, data scientists, and drug developers is working hard to discover a new generation of precision medicines for patients.